Oncology CDMOs are changing the drug industry by making the process of making cancer drugs more accurate, professional, and scalable. One of the biggest problems in modern medicine is cancer. To make good oncology drugs, we need both new scientific ...

Read More

Introduction Selecting a pharmaceutical company that manufactures top-notch oncology medications is essential, particularly as the need for cancer treatment grows. In India, one in nine people will receive a cancer diagnosis at some point in their lives, and every case …

Read More

Is third-party manufacturing the future of pharma? Driven by a push toward cost-saving, specialization, and strict regulatory demands, the pharmaceutical industry is shifting gears fast. Global contract manufacturing is projected to grow from $344.92 billion in 2023 to $604.11 billion …

Read More

How does one turn a promising gene therapy from a concept in the lab into a life-altering medicine for millions? All drugs face complex journeys from the laboratory to the market, but cell and gene therapies require specific differentiated expertise ...

Read More

The pharmaceutical industry is rapidly evolving, with an increasing demand for innovative therapies, particularly in specialized sectors like oncology. Growing pharmaceutical companies face significant challenges in scaling up production while ensuring the highest standards of quality and compliance. This is ...

Read More

The innovations from oncology pharmaceutical companies over recent decades have dramatically changed cancer treatment. Furthermore, new therapies developed by companies have prolonged patients' lives and improved their quality of life. Read further to learn more about the influence of cancer ...

Read More

Diabetes already causes an epidemic worldwide, with 578 million expected by 2030 and 700 million in 2045. In the backdrop of the ever-growing prevalence of diabetes, pharma third-party manufacturing companies face various challenges like high R&D costs, regulatory hurdles, and ...

Read More